Healthcare of Ontario Pension Plan Trust Fund Sells 469,000 Shares of VanEck Pharmaceutical ETF $PPH

Posted by Dante Gardener on Jul 26th, 2026

Healthcare of Ontario Pension Plan Trust Fund trimmed its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 45.5% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 561,000 shares of the company’s stock after selling 469,000 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned about 0.06% of VanEck Pharmaceutical ETF worth $58,277,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Cassaday & Co Wealth Management LLC bought a new stake in shares of VanEck Pharmaceutical ETF during the 1st quarter worth about $79,000. Independent Financial Group LLC bought a new position in shares of VanEck Pharmaceutical ETF in the 1st quarter valued at approximately $532,000. ARQ Wealth Advisors LLC acquired a new stake in VanEck Pharmaceutical ETF in the 1st quarter worth approximately $938,000. Fifth Third Bancorp acquired a new stake in VanEck Pharmaceutical ETF in the 1st quarter worth approximately $120,000. Finally, Cherry Creek Investment Advisors Inc. lifted its holdings in VanEck Pharmaceutical ETF by 5.3% in the 1st quarter. Cherry Creek Investment Advisors Inc. now owns 13,824 shares of the company’s stock worth $1,436,000 after purchasing an additional 695 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Up 0.6%

Shares of VanEck Pharmaceutical ETF stock opened at $110.63 on Friday. VanEck Pharmaceutical ETF has a 12-month low of $81.74 and a 12-month high of $112.58. The stock has a 50 day moving average price of $106.53 and a two-hundred day moving average price of $105.64. The stock has a market capitalization of $961.37 million, a P/E ratio of 20.21 and a beta of 0.46.

VanEck Pharmaceutical ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, July 7th. Stockholders of record on Wednesday, July 1st were paid a $0.6248 dividend. This represents a $2.50 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date was Wednesday, July 1st.

VanEck Pharmaceutical ETF Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.